CELL_REPORTS
Published: 29 April 2022| Version 1 | DOI: 10.17632/rrdrwv5b9d.1
Contributor:
Description
The raw data of Chiang et al _CELL-REPORTS-D-21-01800
Files
Steps to reproduce
Followed by STAR methods.
Institutions
Ohio State University
Categories
Chronic Lymphocytic Leukemia
Funding
OSU
Computational Modelling
Objective of the Model | NC20220428 |
Typical Input | NC20220428 |
Typical output | NC20220428 |
Computer System Requirements | NC20220428: windows |
Simulation ID | NC20220428 |
Patents
Patent Title | None |
Patent Application | None |
AM Sample Data Template
Sample ID | Sample ID |
Date | 2022-04-28T00:00:00.000Z |
Alloy Type | Fe-Base, Ti-Base, Ni-Base |
Alloy composition | % as shown |
Alloy certificate | Alloy certificate |
Process ID | Process ID: NC20220428 |
AM Process Data Template
Additive Manufacturing Process | ASTM |
Process Parameters | ASTM |
Process Date | 2022-04-28T00:00:00.000Z |
Process Description | word format |
CAD File | CAD |
Process ID | Process ID |
Research Process Flow
Process Flow for Additive Manufacturing | None |
Process Flow for Ex-situ Characterization | None |
Process Flow for In-situ Characterization | None |
Process Flow for Computational Modeling | None |
Software
Available Software | None |
Type | Commercial |
Contact link | None |
Publications
Sample ID | None |
Publication Title | None |
Citation | Noen |
Authors | Chi-Ling Chiang1,2,4, Eileen Y. Hu1,2, Lingqian Chang3,4, Jadwiga Labanowska5, Kevan Zapolnik1.2, Xiaokui Mo6, Junfeng Shi7, Tzyy-Jye Doong1,2, Arletta Lozanski1,2, Pearlly S. Yan1, 2, Ralf Bundschuh1, Logan A Walker1,2, Daniel Gallego-Perez4, Wu Lu8, Meixiao Long1,2, Nyla A. Heerema5, Gerard Lozanski1,2,5 Jennifer A. Woyach1,2, John C. Byrd1,2, Ly James Lee,3 and Natarajan Muthusamy1,2 |
MURI/AUSMURI University
User Name | NC20220428 |
University | the Ohio State University |
Address | Rm441, 12th Ave, COlumbus OH43235 |
Acknowledgement | We are thankful to the patients who supported this research by providing their bone marrow. This work was funded by National Science Foundation (EEC-0914790) and Pelotonia Idea Award. C.C. planned, designed, and performed majority of the study, analyzed data, wrote the initial and subsequent drafts of the paper, and approved the final version of the paper. E.Y.H. performed the in-vitro and in-vivo analysis of HSCs. L.C. designed and contributed to the fabrication of the MEP device, operated the microfluidic system and drug test. P.S.Y, R.B, and L.A.W performed the RNA sequencing and data analysis. K.Z. participated the animal experiments. X.M.M. participated in experimental design and statistical analysis. J.L. and N.H. performed the cytogenetic analysis. T.D., A.L. and G.L. participate the sequencing and mutation analysis. D.G., J.S. and W.L. helped device fabrication. J.A.W. and J.C.B. contributed to the CLL patient care, patient sample acquisition and characterization, translation insight to the experimental designs. N.M. and L.J.L conceived the idea, oversaw the study, sought funding, advised in experimental design and, data interpretation, revised the manuscript and approved the final version of the paper. |
Hardware
Available Hardware | NC20220428 |
Accessibility | NC20220428 |
Contact link | None |
Ex-situ Characterization Data Template
Sample ID | NC20220428 |
Process ID | NC20220428 |
Characterization Type | NC20220428 |
Characterization Instrument | NC20220428 |
Ex-situ Measurement Details | None |
In-situ Characterization Data Template
Sample ID | NC20220428 |
Process ID | NC20220428 |
Characterization Type | NC20220428 |
Characterization Instrument | NC20220428 |
In-situ Measurement Details | NC20220428 |